FSD Pharma forfeits cannabis licences to focus on Covid-19 treatments, firm says

Mugglehead
By Jared GnamJul 30, 2020, 8:03 pm260 pts
Shares of FSD Pharma Inc. (Nasdaq and CSE: HUGE) surged as high as 50 per cent as the company exited the cannabis industry to develop its Covid-19 treatment. In a statement Thursday, FSD Pharma said it’s surrendering Health Canada licences held by subsidiary FV Pharma and will liquidate all of its assets,…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Cannabis Flower Testing Shows THC Potency Widely Inflated In Colorado 68

Best THC Drinks: Top Hemp-Derived Cannabis Beverages for 2025 68

Australian Health Authorities Take Action Against 57 Medical Practitioners Over Cannabis Prescribing Practices 62

Study: More Than a Third of Californians Consumed Cannabis Within Past Three Months 59

Nebraska Medical Cannabis Advocate & CBD Store Owner Running for Governor 53

Patients With Anxiety Fuel Pennsylvania’s $1.7 Billion Medical Cannabis Program 44

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.